Abstract

Use of Domperidone as a Prokinetic and Antiemetic

Author(s): Albright Lisa M

Issue: Mar/Apr 2005 - Health and Wellness

Page(s): 120-125

Download in electronic PDF format for $75

Abstract

Domperidone is a synthetic benzimidazole compound that acts as a dopamine D2 receptor antagonist. Its localization outside the blood-brain barrier and antiemetic properties have made it a useful adjunct in therapy for Parkinson’s disease. There has been renewed interest in antidopaminergic prokinetic agents since the withdrawal of cisapride, a 5-HT4 agonist, from the market. Domperidone also is as a prokinetic agent for treatment of upper gastrointestinal motility disorders. It continues to be an attractive alternative to metoclopramide because it has fewer neurological side effects. Patients receiving domperidone or other prokinetic agents for diabetic gastropathy or gastroparesis should also be managing diet, lifestyle, and other medications to optimize gastric motility.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2005 Pg. 120-125 View Sample	Use of Domperidone as a Prokinetic and Antiemetic Author(s): Albright Lisa M
May/Jun 2003 Pg. 170-174	Five Compounds for Treating Diabetes-Related Conditions Author(s): Meece Jerry
Nov/Dec 2021 Pg. 500	Domperidone 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 203-207	Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Author(s): Phan Ha, DeReese Annie, Day A J, Carvalho Maria
Jul/Aug 2019 Pg. 316	Domperidone 5 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 276-286	Compounding Prokinetic Medications for Companion Animals Author(s): Gaskins Jessica
Mar/Apr 2000 Pg. 88-90	Complications of Diabetes Author(s): Key David M
Jan/Feb 2003 Pg. 21-23	Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Author(s): Vail Jane
Jan/Feb 2006 Pg. 61	Domperidone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Jul/Aug 2003 Pg. 288-291	Basics of Compounding for Raynaud's Disease Author(s): Glasnapp Andrew
Jul/Aug 2000 Pg. 276-279	Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Author(s): Glasnapp Andrew, Schaefer Erin
Jul/Aug 2004 Pg. 265-267	Case Report: Wound Care of a Diabetic Foot Ulcer Author(s): Wynn Tom
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Sep/Oct 2004 Pg. 329-335	Domperidone in Lactation: Use as a Galactagogue Author(s): Albright Lisa M
May/Jun 2012 Pg. 243	Metoclopramide 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 84-87	The Clinical Pharmacist's Role in Compounding for the Diabetic Patient Author(s): Harshbarger Robert, Harshbarger Diana
Mar/Apr 2000 Pg. 103-104	Diabetes Book Reviews Author(s): Reed-Kane Dana
Jan/Feb 1997 Pg. 28	Antiemetic Suppositories of the Gralla Type Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 328	Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Author(s): Allen Loyd V Jr